JP Morgan Chase’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-47,153
Closed -$2.58M 6903
2021
Q3
$2.58M Sell
47,153
-849
-2% -$47.3K ﹤0.01% 3570
2021
Q2
$2.46M Buy
+48,002
New +$2.48M ﹤0.01% 3643
2021
Q1
Sell
-47,153
Closed -$2.64M 6290
2020
Q4
$2.64M Buy
+47,153
New +$2.52M ﹤0.01% 3281
2020
Q1
Sell
-273,486
Closed -$9.8M 5651
2019
Q4
$9.8M Buy
+273,486
New +$10.2M ﹤0.01% 2129

Other funds holding QGEN

JP Morgan Chase's QGEN Position: Q1 2026 in Review

JP Morgan Chase reduced its Qiagen (QGEN) stake by 42% in Q1 2026, selling an estimated $17.8M and leaving 511,485 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

JP Morgan Chase first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $236M in Q1 2020. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • JP Morgan Chase held 511,485 shares of Qiagen worth $20.1M as of Q1 2026.
  • JP Morgan Chase sold 375,337 Qiagen shares in Q1 2026, an estimated $17.8M.
  • Qiagen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2064 holding.
  • JP Morgan Chase first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
  • JP Morgan Chase's Qiagen position peaked at $236M in Q1 2020.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.